drugset / Trial / NCT00643669
24 Hour IOP Lowering Efficacy of AL-3789
RandomizedSingle-groupSingle-blindTreatment
Summary
The objective of this study was to describe the intraocular pressure-lowering efficacy of AL-3789 over a 24-hour period in patients with open-angle glaucoma compared to an untreated control. Patients received one treatment of AL-3789. Twenty-eight days after treatment, IOP was measured every 4 hours, beginning at 8 AM for 24 hours.
Timeline
- Start
- 2008-02
- Primary completion
- 2008-04
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Anecortave Acetate | Small molecule | 0.8 ml | Other |